Thursday, August 18, 2016
Thursday, July 7, 2016
Asthma: Inhalers and Nebulizers
http://www.webmd.com/asthma/guide/home-nebulizer-therapy
A nebulizer changes medication from a liquid to a mist so that it can be more easily inhaled into the lungs. Nebulizers are particularly effective in delivering asthma medications to infants and small children and to anyone who has difficulty using an asthma inhaler.
It is also convenient when a large dose of an inhaled medication is needed. Nebulized therapy is often called a "breathing treatment." And a variety of medications -- both for immediate relief and maintenance of asthma symptoms -- are available for use with a nebulizer.
Nebulizers come in home (tabletop) and portable models. Home nebulizers are larger and must be plugged into an electrical outlet. Portable nebulizers run on batteries -- either disposable or rechargeable -- or can be plugged into a car's cigarette lighter. Smaller, portable units are slightly larger than a deck of cards, so they can be carried in a purse, briefcase, or backpack to be used whenever and wherever you need them.
To obtain a nebulizer, you need a prescription from your doctor, or it can be dispensed from your pediatrician’s office. (Oftentimes, a breathing treatment is administered at the doctor’s office.)
Nigeria: International SOS Emergency Clinic Lagos
Nigeria in Lagos, West Africa
https://www.internationalsos.com/locations/africa/Nigeria
Ikoyi
Lagos
Lagos
Tel: Tel: +234 (0) 1 462 5600
Email: LagosClinic@internationalsos.com
Office Hours: Monday to Friday 08h00 - 18h00 Saturday 08h00 - 18h00 Sunday Emergencies only
Our Lagos facility was established in February 2003 and was relocated to Ikoyi in November 2008. The clinic is in the secluded area of Thomson Road, a short distance from the top of Kingsway by Osborne Road, offering a better strategic location for MEDEVACs, and in the heart of Ikoyi, Lagos’ major residential area. We offer general practice consultations, treatment and emergency medical care.
Our experienced expatriate and national doctors, together with our national nurses are also supported by our Port Harcourt clinic and the International SOS global infrastructure. The clinic is on-call to offer full 24/7 emergency cover.
The clinic facilities include:
Our medical team also provides the following services:
International SOS Clinics in Nigeria are accessible only via a separate agreement plan. For more details of all our services, please call or email us.
https://www.internationalsos.com/locations/africa/Nigeria
International SOS Clinic Lagos
23A Temple Road (Olu Holoway road)Ikoyi
Lagos
Lagos
Tel: Tel: +234 (0) 1 462 5600
Email: LagosClinic@internationalsos.com
Office Hours: Monday to Friday 08h00 - 18h00 Saturday 08h00 - 18h00 Sunday Emergencies only
Our Lagos facility was established in February 2003 and was relocated to Ikoyi in November 2008. The clinic is in the secluded area of Thomson Road, a short distance from the top of Kingsway by Osborne Road, offering a better strategic location for MEDEVACs, and in the heart of Ikoyi, Lagos’ major residential area. We offer general practice consultations, treatment and emergency medical care.
Our experienced expatriate and national doctors, together with our national nurses are also supported by our Port Harcourt clinic and the International SOS global infrastructure. The clinic is on-call to offer full 24/7 emergency cover.
The clinic facilities include:
- three consulting rooms
- a fully-equipped emergency room complete with patient monitoring and emergency resuscitation equipment
- a well-equipped laboratory
- a digital x-ray unit
- a pharmacy
- a critical care unit
- a ward
- an ambulance
- a separate occupational health unit with consultation room and audiology facilities
Our medical team also provides the following services:
- immunization programs
- well-baby and pediatric care
- annual health checks and screenings
- travel health advice
- first aid training and training kits
- lectures on various medical or health-related topics
- development of emergency response plans
International SOS Clinics in Nigeria are accessible only via a separate agreement plan. For more details of all our services, please call or email us.
Friday, July 1, 2016
List of hospitals in Lagos - Wikipedia, the free encyclopedia
List of hospitals in Lagos - Wikipedia, the free encyclopedia
Lagos is a city in Nigeria, West Africa
Lagos is a city in Nigeria, West Africa
Sunday, June 12, 2016
Friday, March 27, 2015
The NIOSH Science Bog has been updated: Violence in Healthcare
The NIOSH Science Bog has been updated: Violence in Healthcare
In 2013, healthcare workers reported an estimated 9,200 workplace violence incidents requiring time away from work. Read how to protect healthcare workers from fatal and nonfatal violence on theNIOSH Science Blog.
Sunday, February 22, 2015
Wednesday, February 11, 2015
Consumer Updates Milk-Allergic? There May Be Milk in That Dark Chocolate
Consumer Updates Milk-Allergic? There May Be Milk in That Dark Chocolate
If you or someone in your household is allergic to milk, take heed: a recent study by the Food and Drug Administration (FDA) tested 100 dark chocolate products and found that many contained milk. More importantly, you can’t always tell that’s the case simply by reading the food label.
“This can be a problem, since even one small bite of a product containing milk can cause a dangerous reaction in some individuals,” says researcher Binaifer Bedford, M.S., an Oak Ridge Institute for Science and Education (ORISE) fellow at FDA.
Milk is one of eight major food allergens (the others are wheat, eggs, peanuts, tree nuts, fish, Crustacean shellfish and soybeans). U.S. law requires foods containing a major food allergen to provide its name—in this case, milk—on the label. This is one of the ways to help ensure consumers know what’s in the food they’re eating. Undeclared (not listed on the label) allergens are a leading cause of food recall requests by the FDA.
From September 2009 to September 2012, about one-third of foods reported to FDA as serious health risks involved undeclared allergens. The five food types most often involved in food allergen recalls were bakery products, snack foods, candy, dairy products and dressings. Within the candy category, there were many reports of undeclared milk in dark chocolate.
A manufacturer may not intend to use milk in a dark chocolate product, Bedford says. But if the dark chocolate product shares equipment with, for example, a milk chocolate product, traces of milk may inadvertently wind up in the dark chocolate. After hearing from consumers who had eaten dark chocolate and experienced harmful reactions, FDA tested 100 dark chocolate bars for the presence of undeclared milk. The selected bars were obtained from different parts of the U.S. and each bar was unique in terms of product line and/or manufacturer.
“We divided the bars into categories based on the statements on the labels,” Bedford explains. The categories included precautionary statements such as “may contain milk” or “may contain traces of milk”; statements such as “dairy-free” or “allergen-free”; no mention of milk on the label; and inconsistent statements.
Even a consumer who carefully reads the label may be confused by a statement such as “vegan” (which implies that no animal-derived products were used) along with a precautionary statement referring to the presence of milk, Bedford says. Moreover, a consumer will not know how much or whether milk is present when a product is labeled “may contain traces of milk,” or when the product was manufactured with the same equipment used for products containing milk.
What the FDA Study Found
“First of all, milk-allergic consumers should be aware that a high proportion of the dark chocolates we tested contained milk, even when the label failed to list milk as an ingredient,” Bedford says. Of greatest concern are chocolate samples that have no statement regarding milk on the label or have inconsistencies in the label. Several of the chocolates labeled “dairy free” were also found to contain milk.
Results included:
- While dark chocolates labeled “dairy free or allergen-free” were the least likely to contain milk, two out of 17 of these products were found to contain milk.
- All seven bars that declared the presence of milk on the label contained milk; however, 55 (59%) of 93 bars without any clear indication of the presence of milk also were found to contain milk.
- Six out of the eleven chocolate products labeled “traces of milk” contained milk at detectable levels high enough to potentially cause severe reactions in some individuals.
Wednesday, January 28, 2015
Thursday, November 6, 2014
Wednesday, September 10, 2014
Sunday, September 7, 2014
Friday, July 18, 2014
Recalls, Market Withdrawals, & Safety Alerts Baxter Initiates Voluntary Worldwide Recall Of Four Lots Of IV Solutions Due To The Presence Of Particulate Matter
Recalls, Market Withdrawals, & Safety Alerts Baxter Initiates Voluntary Worldwide Recall Of Four Lots Of IV Solutions Due To The Presence Of Particulate Matter
FOR IMMEDIATE RELEASE - July 14, 2014 – Baxter International Inc. announced today it is voluntarily recalling four lots of intravenous (IV) solutions to the hospital/user level. These products have been found to contain particulate matter identified as cellulosic fibers and/or plastics. Baxter received four complaints over a period of six months from customers whose visual inspection identified the appearance of visible particulate matter prior to administration to a patient.
If infused, adverse health consequences of particulate matter could vary depending on the amount of particulate matter injected into the patient, the size of the particles, the patient’s underlying medical condition and the presence of a right-to-left cardiac shunt. The presence of particulate foreign matter may elicit inflammatory and allergic responses, both chronic and acute, and may be life threatening. There have been no reported adverse events associated with this issue to date, and an investigation is underway to determine root cause.
Products affected by this recall are found in the table below:
| Product Code | Description | Lot # | Expiry Date | NDC |
|---|---|---|---|---|
| 2B1302 | 0.9% Sodium Chloride 100 mL (Quad Pack) | P298190 | Aug 2014 | 0338-0049-18 |
| 2B0043 | 0.9% Sodium Chloride 100 mL MINI-BAG Plus | P308650 | Oct 2014 | 0338-0553-18 |
| 2B1306 | 0.9% Sodium Chloride, 50 mL (Single Pack) | P309187 | Oct 2014 | 0338-0049-41 |
| 2B0822 | Highly Concentrated Potassium Chloride Injection, 20 mEq/50 mL, VIAFLEX Plus Container | P309476 | Oct 2014 | 0338-0703-41 |
Sodium Chloride Injection, USP is an intravenously administered injectable indicated as a source of water and electrolytes, for use as a priming solution in hemodialysis procedures, and may be used as a diluent for reconstitution of a powdered drug product. Potassium Chloride Injection is an intravenously administered injectable indicated as a potassium replacement to support nerve conduction, muscle contraction and prevention of cardiac arrhythmias. The lots being recalled were distributed worldwide to customers and distributors between February 2013 and June 2014.
Baxter has notified customers, who are being directed not to use products from the recalled lots. Recalled products should be returned to Baxter for credit by contacting Baxter Healthcare Center for Service at 1-888-229-0001, Monday through Friday, between the hours of 7:00 a.m. and 6:00 p.m., Central Time. Unaffected lots of product are available for replacement.
Consumers with questions regarding this recall can call Baxter at 1-800-422-9837, Monday through Friday, between the hours of 8:00 a.m. and 5:00 p.m. Central Time, or e-mail Baxter at onebaxter@baxter.com. Consumers should contact their physician or healthcare provider if they have experienced any problems that may be related to using these drug products.
Adverse reactions or quality problems experienced with the use of these products may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.
- Complete and submit the report Online: www.fda.gov/medwatch/report.htm
- Regular Mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.
About Baxter
Baxter International Inc., through its subsidiaries, develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, cancer, infectious diseases, kidney disease, trauma and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
Subscribe to:
Posts (Atom)